Search company, investor...


Founded Year



Other Investors | Alive

About CellMax

Headquarters Location

Atidim building 7 Entrance 2 Entrance 2, Floor 2



(+9) 723-648-4223

Missing: CellMax's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: CellMax's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest CellMax News

VIDEO: GO2 awardee lecture a ‘highlight’ of International Lung Cancer Congress

Aug 26, 2020

Healio Interview Disclosures: Gandara reports receiving research support from Merck, Novartis and Roche-Genentech and serving as a consultant for AstraZeneca, Celgene, CellMax, FujiFilm, Roche-Genentech, Guardant Health, Inivata, IO Biotech, Lilly, Merck and Samsung Bioepis. ADD TOPIC TO EMAIL ALERTS Receive an email when new articles are posted on Please provide your email address to receive an email when new articles are posted on . Please try again later. If you continue to have this issue please contact . Back to Healio In this video, David R. Gandara, MD, director of the thoracic oncology program at UC Davis Comprehensive Cancer Center, discussed a lecture given by Charles Swanton, MD, PhD, FRCP, FMedSci, FRS, at this year’s virtual International Lung Cancer Conference Swanton discussed lung cancer cells’ evolution in resistance to treatments. Swanton is the recipient of the 2020 GO2 Foundation for Lung Cancer Bonnie J. Addario lectureship award, which has recognized experts for over a decade. “[Swanton] has made the concept of cancer evolution and the genomics of the cancer and the immunology phenotype a reality from his research. That was really a highlight of the meeting,” Gandara said. Gandara said the lecture included the measurement of circulating tumor DNA in blood to advance strategies to monitor cancer, improve patient survival and outcomes.

CellMax Frequently Asked Questions (FAQ)

  • When was CellMax founded?

    CellMax was founded in 2003.

  • What is CellMax's latest funding round?

    CellMax's latest funding round is Other Investors.

  • Who are the investors of CellMax?

    Investors of CellMax include Wolfson Group.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.